Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

RECAGE · How to best meet the needs of people with dementia with severe behavioural disturbances. Toward a respectful and cost-effective model

H2020Status: CLOSED1 January 201830 June 2023EU funding €2,824,038Call H2020-SC1-2016-2017

The RECAGE project will tackle one of the most challenging problem arising during the clinical course of dementia: the so-called Behavioural and Psychological Symptoms of Dementia (BPSD). The current state-of-the-art of the treatment of these symptoms is still unsatisfactory and there are many unmet needs in this area. The major objective of the project will be to assess the effectiveness of an intervention, the special medical care unit for patients with BPSD (SCU-B), that, albeit already implemented in some European countries, is not widespread and has not been sufficiently studied so far, although it seems to be promising for its short-term efficacy (alleviating BPSD and improving quality of life of PwD) and possibly for its long term efficacy.In order to achieve this goal, RECAGE will proceed in three steps:1) A prospective cohort study, comparing the activity of the centres endowed with a typical SCU-B with that of the other participating centres lacking this facility; the efficacy and the cost-effectiveness of the proposed intervention will be tested in the prospective study. The expected benefits are socially appreciable: improving quality of life of persons with dementia, lessening caregivers' burden, possibly delaying institutionalisation2) A conference aiming at adapting the SCU-B model in accordance with the results of the cohort study, not only regarding its main endpoints, but also comparing the experience and the different ways of operating of the participating centres and the different socio-political context in which they act3) A plan for scaling up the intervention in the countries who take part in the study, but where SCU-Bs are absent or sporadic as Italy and Greece.

Consortium · 20 organisations

coordinator

FONDAZIONE EUROPEA DI RICERCA BIOMEDICA-FERB ONLUS

IT · €622,463

participant

CLINICHE GAVAZZENI SPA

IT · €151,885

participant

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

FR

participant

AZIENDA UNITA SANITARIA LOCALE DI MODENA

IT · €167,485

participant

UNIVERSITE DE GENEVE

CH · €236,500

participant

REGIONE EMILIA ROMAGNA

IT · €68,521

participant

ASSOCIATION HOSPITALIERE DE BRUXELLES-CENTRE HOSPITALIER UNIVERSITAIRE SAINT PIERRE

BE · €12,153

participant

ARISTOTELIO PANEPISTIMIO THESSALONIKIS

EL · €159,819

participant

ASSISTANCE PUBLIQUE HOPITAUX DE PARIS

FR · €167,375

participant

UNIVERSITEIT MAASTRICHT

NL · €59,000

participant

AZIENDA SOCIO SANITARIA TERRITORIALE DI MANTOVA(ASST DI MANTOVA)

IT · €157,385

participant

CHARITE - UNIVERSITAETSMEDIZIN BERLIN

DE · €161,500

participant

ELLINIKI ETAIRIA NOSOY ALZHEIMER KAI SYGGENON DIATARACHON SOMATEIO

EL · €78,860

participant

SYKEHUSET INNLANDET HF

NO · €129,000

participant

ALZHEIMER ITALIA - FEDERAZIONE DELLE ASSOCIAZIONI ALZHEIMER D'ITALIA

IT · €78,310

thirdParty

UNIVERSITE PARIS CITE

FR

participant

ZENTRALINSTITUT FUER SEELISCHE GESUNDHEIT

DE · €165,426

participant

UNIVERSITA DEGLI STUDI DI PERUGIA

IT · €160,771

participant

ETAIRIA NOSOU ALZHEIMER KAI SINAFONDIATARAXON ATHINON SOMATEIO

EL · €73,418

participant

MEDIOLANUM CARDIO RESEARCH SRL

IT · €174,167

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.